Funder: Novo Nordisk Foundation
Due Dates: March 19, 2026 (Phase 1 concept note) | August 12, 2026 (Phase 2 full application)
Funding Amounts: Up to DKK 15 million per grant (3–5 years); total DKK 75 million available in 2026 call.
Summary: Supports international collaborative research to advance understanding of sex-related differences in cardiovascular disease, with a focus on improving women’s heart health.
Key Information: Main applicant must be based in a Nordic country; international collaboration is mandatory.